Actively Recruiting
New Strategies to Enhance Smoking Cessation
Led by University of Chicago · Updated on 2025-06-11
94
Participants Needed
1
Research Sites
292 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study goal is to get feedback on ways researchers can communicate complex research findings on smoking cessation to better inform patients' decisions to use medication and/or quit smoking. This will help researchers and clinicians to provide effective, easy-to-implement treatments designed to address tobacco-related health disparities in Black and other racial/ethnic subgroups. It will also help improve health literacy to change misperceptions and mistrust on uptake of varenicline and other medication for quitting smoking. A professionally made video will explain research findings relevant for varenicline's mechanisms and outcomes relative to other treatment options. There are 2 parts to this study: * Part 1: Focus Group to help develop the educational tool intervention * Part 2: Randomized portion of study. In this part of the study, participants will be randomized (like flip of coin) to take part in receive the experimental educational intervention or usual methods to help stop smoking. Participants in either arm can choose to receive varenicline and it will be provided as part of study.
CONDITIONS
Official Title
New Strategies to Enhance Smoking Cessation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Smoke at least 10 cigarettes per day
- Not currently using any smoking cessation medication
- Aged between 18 and 75 years
- Willing to complete study surveys and assessments
- Able to understand English and willing to sign informed consent
You will not qualify if you...
- Currently using any other smoking cessation medications
- Pregnant or breastfeeding
- Psychiatric conditions that prevent following study procedures or using study tools, assessed individually
- Contraindications to varenicline use
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Chicago
Chicago, Illinois, United States, 60637
Actively Recruiting
Research Team
C
Clinical Trials Intake
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here